Regulatives Submission Issues [Study As­sess­ment]

posted by balakotu – India, 2014-05-19 16:06 (4415 d 08:03 ago) – Posting: # 12970
Views: 6,224

Dear All,

Please clarify the below query

We conducted fed pivotal BE study. The clinical phase of study is initiated with 36 subjects as per protocol, out of 36 subjects only 17 Subjects completed the analysis. Whether we can submit the BE data with this less number of subjects (N=17 Subjects). Please share your thoughts on regulatory concerns in such cases of high dropouts.

Regards
Kotu.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
144 visitors (0 registered, 144 guests [including 21 identified bots]).
Forum time: 00:09 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5